Literature DB >> 161246

Site-specific mutagenesis using synthetic oligodeoxyribonucleotide primers: II. In vitro selection of mutant DNA.

S Gillam, M Smith.   

Abstract

A method for the in vitro selection of mutant DNA has been devised as an adjunct to the recently developed method for the use of short enzymatically-synthesized oligodeoxyribonucleotides of defined sequence as site-specific mutagens for circular DNA. The selection method uses the mutating oligodeoxyribonucleotide as a primer for Escherichia coli DNA polymerase I (large fragment) under conditions where there is preferential interaction with mutant DNA template. After ligation using T4 DNA ligase, endonuclease S1 is used to degrade single-stranded non-mutant DNA leaving the desired mutant as closed circular duplex DNA. This paper describes the development of the method using mutants in phi X174 DNA as the model system. Studiies on the changes A leads to G and G leads to A at position 587 of phi X174 viral DNA (am3 to wild-type and its reversal) show that one or two cycles of selection can lead to a population of phage consisting of close to 100% mutants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 161246     DOI: 10.1016/0378-1119(79)90010-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  19 in total

1.  The use of site-directed mutagenesis, transient transfection, and radioligand binding. A method for the characterization of receptor-ligand interactions.

Authors:  J G Newell; M Davies; A N Bateson
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

2.  Simultaneous synthesis of human-, mouse- and chimeric epidermal growth factor genes via 'hybrid gene synthesis' approach.

Authors:  W L Sung; D M Zahab; F L Yao; R Wu; S A Narang
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

3.  Site-directed mutagenesis of the Klebsiella pneumoniae nifL and nifH promoters and in vivo analysis of promoter activity.

Authors:  M Buck; H Khan; R Dixon
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.

Authors:  Caroli Genis; Katherine H Sippel; Nicolette Case; Wengang Cao; Balendu Sankara Avvaru; Lawrence J Tartaglia; Lakshmanan Govindasamy; Chingkuang Tu; Mavis Agbandje-McKenna; David N Silverman; Charles J Rosser; Robert McKenna
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

6.  Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.

Authors:  O Kashles; D Szapary; F Bellot; A Ullrich; J Schlessinger; A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Introduction of restriction enzyme sites in protein-coding DNA sequences by site-specific mutagenesis not affecting the amino acid sequence: a computer program.

Authors:  R Arentzen; W C Ripka
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

8.  Oligonucleotide directed mutagenesis of the human beta-globin gene: a general method for producing specific point mutations in cloned DNA.

Authors:  R B Wallace; M Schold; M J Johnson; P Dembek; K Itakura
Journal:  Nucleic Acids Res       Date:  1981-08-11       Impact factor: 16.971

9.  Oligonucleotide-directed mutagenesis as a general and powerful method for studies of protein function.

Authors:  G Dalbadie-McFarland; L W Cohen; A D Riggs; C Morin; K Itakura; J H Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

10.  Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor.

Authors:  E Livneh; T J Dull; E Berent; R Prywes; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.